GTX Inc (NASDAQ:GTXI)

0.77
Data as of Dec 24
 -0.05 / -6.10%
Today’s Change
0.41
Today|||52-Week Range
2.35
-53.33%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$119.2M

Company Description

GTx, Inc. is a biopharmaceutical company. It engages in the discovery, development and commercialization of small molecules for the treatment of cancer, including treatments for prostate and breast cancer, cancer supportive care, including prevention and treatment of cancer-related muscle wasting or cachexia, and other serious medical conditions. The company also develops selective androgen receptor modulators, a new class of drugs with the potential to prevent and treat muscle wasting in patients with cancer and other musculoskeletal wasting or muscle loss conditions, including chronic sarcopenia, as well as the potential to be used as a hormonal therapy for the treatment of metastatic breast cancer. Its SARM product candidate, enobosarm (GTx-024), has to date been evaluated in fourteen completed or ongoing clinical trials enrolling approximately 1,320 subjects, including in three Phase 2 and two Phase 3 clinical trials. GTx was founded by Marc Steven Hanover and Mitchell Shuster Steiner on September 24, 1997 and is headquartered in Memphis, TN.

Contact Information

GTx, Inc.
175 Toyota Plaza
Memphis Tennessee 38103
P:(901) 523-9700
Investor Relations:
(901) 507-6915

Employees

Shareholders

Other institutional9.30%
Individual stakeholders66.54%
Mutual fund holders0.84%

Top Executives

Marc Steven HanoverPresident, Chief Executive Officer, COO & Director
Jason T. ShackelfordCFO, CAO, Accounting Director & Controller
Mary Ann JohnstonVP-Medical Affairs & Clinical Operations
Henry Patton DoggrellSecretary, Chief Legal Officer & Vice President
Jeffrey G. HesselbergVice President-Regulatory Affairs

To view my watchlist

Not a member yet?

Sign up now for a free account

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.

Morningstar: © 2014 Morningstar, Inc. All Rights Reserved.

Factset: FactSet Research Systems Inc. 2014. All rights reserved.

Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2014 and/or its affiliates.